China
After Raising $300 Million, China’s Abogen Hunkers Down on mRNA Covid-19 Vaccine with GenScript and Walvax
2021-12-01
China’s Neurophth Snags $63 Million in Series C to Boost Ophthalmic Gene Therapy Portfolio
2021-11-25
How is China Driving Global Progress in Innovation and Access? – A Discussion with BeiGene CEO John Oyler
2021-11-16
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115